Porrett receives Heersink School of Medicine's Featured Discovery Award for groundbreaking xenotransplantation research
Written by Kayla GibsonPaige M. Porrett, M.D., Ph.D., associate professor in the Department of Surgery, has recently been honored with the Heersink School of Medicine's Featured Discovery award. She has been awarded alongside the first authors Rebecca Asiimwe, bioinformatician III in the Porrett Lab, and Matthew D. Cheung, a medical scientist graduate trainee. This initiative recognizes significant research contributions from Heersink faculty members.
The UAB Medicine Leadership Competency Model features five domains and 19 competencies. In this series, we’ll examine this model and how it can be used to empower leadership.
Progress never pauses
Written by Anupam Agarwal, M.D.UAB Medicine’s Leadership Development Office recognized 16 individuals in its eighth cohort of Institute for Leadership at a graduation ceremony on June 26, 2024.
Upcoming Access to Volker Hall
Written by Phillip PinyanHeersink Institute Leadership Attend Symposium on AI in Health Care at Maastricht University
Written by Emily Liming JohnsUniversity of Alabama at Birmingham (UAB) faculty members recently participated in the AI in Medicine and Healthcare Symposium at Maastricht University, which brought together experts and stakeholders to discuss the role of artificial intelligence (AI) in transforming health care.
Newsom completes Phase 2 clinical trial of a novel drug for Pitt-Hopkins Syndrome
Written by Mary Ashley CanevaroCassandra Newsom, Psy.D., director of the Translational Research Core in Autism and Neurodevelopment of Civitan International Research Center, has completed participation in Phase 2 Clinical Trials of a new drug, NNZ-2591, that shows promising results for a devastating neurodevelopmental disorder called Pitt-Hopkins Syndrome (PTHS).
Two researchers named Emerging Scholar Award winners for 2024-2025
Written by Mary Ashley Canevaro and Joy MarschTwo researchers have been named Civitan Emerging Scholars for 2024-2025 by the Civitan International Research Center for neurodevelopmental disorders.